Stockreport

VEOZAH® (fezolinetant film-coated tablets) Receives Health Canada Approval as First and Only Non-hormonal Treatment for Vasomotor Symptoms (VMS) Associated with Menopause [Yahoo! Finance]

ASTELLAS PHARMA UNSP/ADR  (ALPMY) 
NASDAQ:AMEX Investor Relations: astellas.com/jp/en/investors
PDF MARKHAM, ON Dec. 3, 2024 /CNW/ - Today, Astellas Pharma Canada, Inc. is proud to announce the Health Canada approval of VEOZAH ® (fezolinetant film-coated tablets), the [Read more]